Filter your results
- 4
- 4
- 4
- 2
- 2
- 4
- 4
- 3
- 2
- 1
- 1
- 1
- 1
- 4
- 4
- 4
- 3
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
sorted by
|
Synthesis of peptidomimetics and chemo-biological tools for CD95/PLC gamma 1 interaction analysisBioorganic and Medicinal Chemistry Letters, 2019, 29 (16), pp.2094-2099. ⟨10.1016/j.bmcl.2019.07.006⟩
Journal articles
hal-02278513v1
|
|||
Probing the side chain tolerance for inhibitors of the CD95/PLCγ1 interactionBioorganic and Medicinal Chemistry Letters, 2019, 29 (21), pp.126669. ⟨10.1016/j.bmcl.2019.126669⟩
Journal articles
hal-02393634v1
|
|||
Disrupting the CD95-PLC gamma 1 interaction prevents Th17-driven inflammationNature Chemical Biology, 2018, 14 (12), pp.1079-+. ⟨10.1038/s41589-018-0162-9⟩
Journal articles
hal-01976911v1
|
|||
HIV Protease Inhibitors Cure Lupus-Prone Mice and Prevent T Helper 17 Cell-Driven Inflammation By Inhibiting CD95-Non-Apoptotic Signaling PathwayArthritis & rheumatology, 2018, 70 (suppl 10)
Journal articles
hal-01940201v1
|